样式: 排序: IF: - GO 导出 标记为已读
-
This Month in JAAD Reviews: November 2024: Permanent drug-induced alopecia J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Shari R. Lipner MD PhD
-
This Month in JAAD Reviews: October 2024: A link between incontinentia pigmenti and squamous cell carcinoma J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Shari R. Lipner MD PhD
-
Taking hydroxychloroquine to heart J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Warren R. Heymann MD
-
This month in JAAD: October 2024 J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Dirk M. Elston MD
-
Impact of wrinkles on the dermatoscopic pattern of solar lentigines: A longitudinal clinical study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-27 Romain de Dormael MSc, Thierry Passeron MD PhD, Audrey Gueniche PharmD PhD, Edouard Raynaud MD, Christine Duval PhD, Philippe Bastien PhD, Virginie Hourblin MSc
-
Side effect profile and expectations with sclerotherapy across Fitzpatrick skin types J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-26 Michelle Lazar BS, Henriette De La Garza MD, Neelam A. Vashi MD
-
Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A–induced nuclear and mitochondrial DNA injury: A pilot randomized clinical study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-25 Erika McCormick MD, Haowei Han DO, Sara Abdel Azim MS, Cleo Whiting BS, Nitish Bhamidipati, Alexi Kiss MD, Tatiana Efimova PhD, Brian Berman MD PhD, Adam Friedman MD
UV-A radiation contributes to photoaging/photocarcinogenesis by generating inflammation and oxidative damage. Current photoprotective strategies are limited by the availability/utilization of UV-A filters, highlighting an unmet need. Cannabidiol (CBD), having anti-inflammatory/antioxidant properties via regulation of nuclear erythroid 2–related factor, heme oxygenase 1, and peroxisome proliferator-activated
-
Increasing survival for melanoma with bony metastases in the era of novel therapies: A population-based retrospective analysis J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-25 Connor J. Tupper MD, Laura M. Cogua BS, Peter T. Silberstein MD
-
Ethics of residents receiving bonus pay based on clinical productivity J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-24 Albert E. Zhou MD PhD, Neelesh P. Jain MD, Christian Gronbeck MD, Elnara Muradova MD, Philip Kerr MD, Steven Brett Sloan MD, Jane M. Grant-Kels MD
-
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-23 Elena Pezzolo MD, Alessandra Narcisi MD, Luigi Gargiulo MD, Vito Di Lernia MD, Maddalena Napolitano MD PhD, Cataldo Patruno MD PhD, Simone Ribero MD PhD, Michela Ortoncelli MD, Caterina Foti MD, Paolo Romita MD, Carlotta Gurioli MD, Donatella Schena MD, Silvia Mariel Ferrucci MD, Francesca Barei MD, Giuseppe Fabrizio Amoruso MD, Filomena Russo MD, Luigi Naldi MD
-
Analysis of dermatology away rotations available on the Visiting Student Learning Opportunities database and implications for diversity in dermatology: A national cross-sectional study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-22 Zahna Bigham BA, Ruhi Kanwar BS, Sofia Milosavljevic BA, Nana Ama Adjei-Frimpong BA, Carlos Salazar BS, Vinod E. Nambudiri MD MBA EdM
-
Ethics of dermatologists having to manage cosmetic complications by other clinicians J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-22 Albert E. Zhou MD PhD, Neelesh P. Jain MD, Brett Sloan MD, Jane M. Grant-Kels MD, Hao Feng MD MHS
-
Adverse events in cemiplimab therapy for locally advanced or metastatic cutaneous squamous cell carcinoma: A global propensity-matched retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-22 Deepika Narayanan MD, Kyle C. Lauck MD, Stanislav N. Tolkachjov MD
-
Challenges in designing studies assessing birth complications and spontaneous abortion in pregnant patients with pityriasis rosea J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-22 Michael M. Ong BS, Shari R. Lipner MD PhD
-
Efficacy of botulinum toxin in male androgenetic alopecia: A triple-blind, randomized clinical trial J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-22 Daniel Fernandes Melo MSc MD, Paulo Müller-Ramos PhD MD, Rita Fernanda Cortez de Almeida MD, Carla Jorge Machado PhD, Sidney Frattini MD, André Luiz Vairo Donda MD, Daniela Alves Pereira Antelo PhD MSc MD, Carlos Baptista Barcaui PhD MSc MD
-
Impact of store-and-forward consumer to physician teledermatology as compared to in-person visits for patients with periorificial dermatitis: A retrospective study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Vrusha K. Shah MPH, Alexandria Tso BS, Deesha D. Desai BS, Joseph C. English III MD
-
Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 David I. Latoni MPH, Yevgeniy R. Semenov MD MA, Hensin Tsao MD PhD
Although the recent drop in melanoma mortality has been attributed to the introduction of newer therapies, the impact of ongoing public efforts remains unknown. Characterize and model melanoma mortality trends before the era of molecular and immune therapies (1969-2014) in the U.S. and Australia. Differential time series analysis based on population-ascertained melanoma mortality rates from the U.S
-
Ethical considerations of assigning scribes to dermatology residents J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Ishani H. Rao BS, Albert E. Zhou MD PhD, Neelesh P. Jain MD, Christian Gronbeck MD, Philip Kerr MD, Steven Brett Sloan MD, Jane M. Grant-Kels MD
-
JAAD Game Changers: “The use of oral antibiotics before isotretinoin therapy in patients with acne” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Adam Friedman MD
-
JAAD Game Changers: Clustering of autoimmune diseases in patients with rosacea J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Adam Friedman MD
-
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Yan Zhao MD, Litao Zhang MD, Jianzhong Zhang MD, CM310AD005 Study Investigators
-
Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: A retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Jenny Lai PhD, Andrea L. Zaenglein MD, John S. Barbieri MD MBA
-
Response to Hasan et al’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Kuan-Jou Wu MD, Kai-Che Wei MD
-
Improving melanoma reporting: The Ohio Model J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-20 Matthew DaCunha MD, Michael Tassavor MD, Madalyn Bland South BS, Brett Coldiron MD
-
This Month in JAAD International: September 2024: Sun protection practices among skin cancer patients in Asia J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-19 Jonathan Kantor MD MSc MSCE
-
JAAD Game Changers: “Cutaneous adverse events of anti–programmed cell death-1 therapy in patients with metastatic melanoma: A single-institution cohort” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-18 Adam Friedman MD
-
JAAD Game Changer: “Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-18 Adam Friedman MD
-
JAAD Game Changers: “Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-18 Adam Friedman MD
-
August 2024 IOTADERMA (#366) J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-18 Robert I. Rudolph MD FACP
-
Time to first skin cancer diagnosis following kidney transplant J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-16 Jacob R. Anderson PhD, Shadmehr Demehri MD PhD
-
Delays in diagnosis in cutaneous T-cell lymphoma: A retrospective study on clinical course and time to death J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Bethany Brumbaugh BS, Beatrix Thompson BA, Allison Holt BS, Joseph Ebriani BS, Katherine Perlman MPH, Chirayu Patel MD MPH, Salvia Jain MD, Jeffrey Barnes MD PhD, Steven Chen MD MPH MHPEd
-
Early postoperative water exposure does not increase complications in cutaneous surgeries: A randomized, investigator-blinded, controlled trial J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Christen Samaan MD, Yesul Kim MD, Shouhao Zhou PhD, Joslyn S. Kirby MD MS Med, Todd V. Cartee MD
Patients are often advised to keep the initial postoperative dressings dry and undisturbed for 24 to 72 hours. However, these requirements may result in significant disruption of patients' activities of daily living, such as bathing, leisure, and exercise. Compare standard management of keeping wounds dry and covered (48 hours) with early (6 hours) postoperative water exposure. Investigator-blinded
-
Ethics of soliciting online reviews in dermatology J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Albert E. Zhou MD PhD, Neelesh P. Jain MD, Christian Gronbeck MD, Brett Sloan MD, Jane M. Grant-Kels MD
-
Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Ambika Nohria BA, Deesha Desai BS, Alison Lee, Theodora Karagounis MD, Jerry Shapiro MD, Michael Garshick MD, Kristen I. Lo Sicco MD
-
Cutaneotropic polyomavirus abundance in the nonlesional skin of keratinocyte carcinoma patients: A cross-sectional study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Eray Yihui Zhou MD MMSc, Yun Xia PhD, Tomonori Oka MD PhD, Hiroshi Higuchi PhD, Tatsuya Hasegawa PhD, Jong Ho Park PhD, Emanuela Marchese PhD, Valeria S. Oliver-García MD, Marjan Azin MD, Danielle N. Conrad BS, Sabrina S. Smith BS, Victor A. Neel MD PhD, Shadmehr Demehri MD PhD
-
Pachyonychia congenita: Spectrum of cutaneous disease J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Kaya L. Curtis BA, Janice Schwartz BA, Holly Evans BS, Shari R. Lipner MD PhD
-
Ethical implications of dermatologists refusing to care for certain diseases J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Neelesh Patrick Jain MD, Jane M. Grant-Kels MD, Hao Feng MD MHS
-
Demographic differences and the impact of research years for reapplicants to dermatology residency programs: A retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Jeremiah S. Truel BA, Sarah Ferree MD, Ramie Fathy MD, Eric Hossler MD, Ilana S. Rosman MD
-
Optical coherence tomography-measured blood vessel characteristics of port-wine birthmarks by depth: A cross-sectional study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Rachel Ann Elsanadi MD, Feben Messele BS, Jaylen Lee PhD, Bernard Choi PhD, Kristen M. Kelly MD
Port-Wine Birthmarks (PWB) are congenital capillary malformations requiring multiple treatments. Optical coherence tomography (OCT), a noninvasive imaging technique, characterizes vessels in cutaneous vascular lesions, including PWBs. To assess variability in blood vessel characteristics within and between individual PWBs. OCT was used to measure blood vessel density (%) and modal vessel diameter (micrometers)
-
Response to Hasan et al’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Po-Cheng Shih MD, James Cheng Chung Wei MD PhD
-
Ethics in using incentives to improve dermatology residents' adherence to case log requirements J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Albert E. Zhou MD PhD, Madeline Brown BS, Neelesh P. Jain MD, Christian Gronbeck MD, Steven B. Sloan MD, Jane M. Grant-Kels MD
-
-
Cons of dermatology practices opting out of Medicare and Medicaid insurances J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Albert E. Zhou MD PhD, Neelesh P. Jain MD, Jane M. Grant-Kels MD
-
Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: A retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 David Garate BS, Christopher J. Thang BS, Jenny Lai PhD, George Golovko PhD, Michael G. Wilkerson MD, John S. Barbieri MD MBA
-
Risk assessment of drugs associated with DRESS syndrome based on publication frequency: A systematic review J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-14 Emma Hansen BA, Matthew Gallardo MD, Allison Yan BA MSc, Rohan Mital MD, Dana Jolley BS, Jacob McFeeters BS, Ashley Gray MD, Beau Sitton MD, Benjamin H. Kaffenberger MD, Abraham M. Korman MD
-
Response to Shih et al. “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-11 Iraj Hasan BA, Zachary Zinn MD
-
Cost-utility and actionability of genomic sequencing for inflammatory linear verrucous epidermal nevus J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 James P. Pham MD, Deshan F. Sebaratnam MBBS MMed
-
“Ethics” vs education: Reconsidering the relationship between academic dermatology and the pharmaceutical industry J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Banu Farabi MD, Mehmet Fatih Atak MD, Banu Mendi MD, Danielle Peterson MD, Shoshana Marmon MD PhD
-
Reconsidering the relationship between academic dermatology and the pharmaceutical industry: Balancing ethics and education of free biologic samples in dermatology J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Maggie Chen BS, Albert E. Zhou MD PhD, Jane M. Grant-Kels MD
-
Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’ J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Aoife Boyle MB BCh BAO, Ian McDonald MB BCh BAO, Dmitri Wall MB BCh BAO
-
Response to the article by Hill and Lipner entitled “Numbers of nail procedures performed by physician assistants and nurse practitioners among Medicare beneficiaries increased 2013-2021” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Carina Shiau BS, Daniel Y. Kim BS, Peter A. Young MPAS, Andrew Baker PA-C MBA, Gordon H. Bae MD
-
Response to Hill et al, “Digital clubbing in cystic fibrosis: The nails as clues to advanced disease” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Aaron D. Smith BS, Gabrielle Schwartzman MD, Catherine E. Lyons BS BA, Hal Flowers MD, Dana Albon MD, Kenneth Greer MD, Kevin Lonabaugh PharmD, Barrett J. Zlotoff MD
-
Digital clubbing in cystic fibrosis: The nails as clues to advanced disease J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Rachel C. Hill BS, Eden Axler BS, Shari R. Lipner MD PhD
-
Slowed-down temporal vein refilling as diagnostic pearl in frontal fibrosing alopecia J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Miguel Mansilla-Polo MD, Daniel Martín-Torregrosa MD, Ignacio Torres-Navarro MD
-
Esthetic and medical tattooing: Part I: Tattooing techniques, implications, and adverse effects in healthy populations and special groups J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-09 Samuel Kassirer MDC, Leonardo Marini MD, Christopher B. Zachary MBBS, Deborah S. Sarnoff MD, Marina Landau MD
Tattooing, the introduction of exogenous pigments into the skin, has a rich history spanning thousands of years, with cultural, cosmetic, and medical significance. With the increasing prevalence of tattoos, understanding their potential complications and contraindications is of growing importance. The most common complications are hypersensitivity reactions, which may vary in morphology and timing
-
Availability of lasers and hands-on training in cosmetic dermatology in residency J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-06 Bianca Y. Kang MD, Erik J. Stratman MD, Jenny C. Hu MD MPH, Rachel Elsanadi BS, Tanya Greywal MD, Kristen M. Kelly MD, Arisa Ortiz MD, Sami K. Saikaly MD, Kathleen C. Suozzi MD, Diana Bolotin MD PhD, Kira Minkis MD PhD, Murad Alam MD MBA MSCI, Cosmetic and Laser Education Working Group, Diana D. Antonovich MD, Anna Bar MD, Alison Boucher MD, Maggie L. Chow MD PhD, M. Laurin Council MD, Loma Dave BS
-
Ethical considerations when you think you suspect elder abuse J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-06 Jaya Manjunath BS, Jane M. Grant-Kels MD
-
Differences in skin cancer surveillance among patients with nonmelanoma skin cancer by race: A retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-06 Marta Taye BA, Kalina T.L. Machado BA, Travis Blalock MD, Loren D. Krueger MD
-
This Month in JAAD CaseReports: September 2024 J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-06 Abby S. Van Voorhees MD
-
Cost-effectiveness of patch testing allergens within the same group: A computational approach to optimize formaldehyde-related allergen selection J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-05 Ning C. McKenzie BA, Matthew R. Buras MS, James A. Yiannias MD, Matthew R. Hall MD, Molly J. Youssef MD, Mark D.P. Davis MD, Yul W. Yang MD PhD
Patch testing for multiple cross-reactive allergens for allergic contact dermatitis (ACD) may not be necessary because of copositivity. We evaluated the formaldehyde group allergens to determine the optimal, most cost-effective allergens to test. A retrospective analysis of Mayo Clinic (1997-2022) examined the well-established copositive formaldehyde group: formaldehyde, quaternium 15, hexahydro-1